These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22958460)

  • 1. Investigation of volatile organic biomarkers derived from Plasmodium falciparum in vitro.
    Wong RP; Flematti GR; Davis TM
    Malar J; 2012 Sep; 11():314. PubMed ID: 22958460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volatile organic compounds associated with Plasmodium falciparum infection in vitro.
    Correa R; Coronado LM; Garrido AC; Durant-Archibold AA; Spadafora C
    Parasit Vectors; 2017 May; 10(1):215. PubMed ID: 28464853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile metabolites differentiate air-liquid interface cultures after infection with
    Ahmed W; Bardin E; Davis MD; Sermet-Gaudelus I; Grassin Delyle S; Fowler SJ
    Analyst; 2023 Jan; 148(3):618-627. PubMed ID: 36597770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breath Biomarkers of Pediatric Malaria: Reproducibility and Response to Antimalarial Therapy.
    Berna AZ; Wang XR; Bollinger LB; Banda J; Mawindo P; Evanoff T; Culbertson DL; Seydel K; Odom John AR
    J Infect Dis; 2024 Oct; 230(4):1013-1022. PubMed ID: 38885291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of breath sampling methods: a post hoc analysis from observational cohort studies.
    Berna AZ; Schaber CL; Bollinger LB; Mwale M; Mlotha-Mitole R; Trehan I; Odom John AR
    Analyst; 2019 Mar; 144(6):2026-2033. PubMed ID: 30702091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breathprinting Reveals Malaria-Associated Biomarkers and Mosquito Attractants.
    Schaber CL; Katta N; Bollinger LB; Mwale M; Mlotha-Mitole R; Trehan I; Raman B; Odom John AR
    J Infect Dis; 2018 Apr; 217(10):1553-1560. PubMed ID: 29415208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Breath Specimens for Biomarkers of Plasmodium falciparum Infection.
    Berna AZ; McCarthy JS; Wang RX; Saliba KJ; Bravo FG; Cassells J; Padovan B; Trowell SC
    J Infect Dis; 2015 Oct; 212(7):1120-8. PubMed ID: 25810441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Proton Transfer Reaction-Mass Spectrometry and electronic nose study of the volatile compounds released by Plasmodium falciparum infected red blood cells in vitro.
    Capuano R; Khomenko I; Grasso F; Messina V; Olivieri A; Cappellin L; Paolesse R; Catini A; Ponzi M; Biasioli F; Di Natale C
    Sci Rep; 2019 Aug; 9(1):12360. PubMed ID: 31451707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
    Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
    J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution metabolomics to discover potential parasite-specific biomarkers in a Plasmodium falciparum erythrocytic stage culture system.
    Park YH; Shi YP; Liang B; Medriano CA; Jeon YH; Torres E; Uppal K; Slutsker L; Jones DP
    Malar J; 2015 Mar; 14():122. PubMed ID: 25889340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.
    Baranska A; Smolinska A; Boots AW; Dallinga JW; van Schooten FJ
    J Breath Res; 2015 Oct; 9(4):047102. PubMed ID: 26469548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of volatile organic compounds for the classification and identification of mycobacterial species.
    Küntzel A; Oertel P; Fischer S; Bergmann A; Trefz P; Schubert J; Miekisch W; Reinhold P; Köhler H
    PLoS One; 2018; 13(3):e0194348. PubMed ID: 29558492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.